Close
Back to mobile site

Veru, Inc. (VERU) Climbs 11%, Covid Treatment to Face FDA Panel on Oct. 6

September 7, 2022 9:17 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Veru, Inc. (NASDAQ: VERU) Climbs 11%, Covid Treatment to Face FDA Panel on Oct. 6



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Momentum Movers, Trader Talk

Related Entities

FDA